Search

Robert Guerrero Phones & Addresses

  • 420 N Tremont St, Oceanside, CA 92054 (760) 967-6630
  • 724 N Pacific St UNIT 1, Oceanside, CA 92054 (760) 967-6630
  • 1472 Belleaire St, Oceanside, CA 92054
  • Sylmar, CA
  • San Diego, CA
  • 13724 Astoria St, Sylmar, CA 91342

Professional Records

License Records

Robert G Guerrero

License #:
4735 - Active
Category:
Tow Truck Operator (Incident Management)
Expiration Date:
Jan 4, 2018

Resumes

Resumes

Robert Guerrero Photo 1

Court-Certifed Interpreter And Career Coach

View page
Position:
Court Interpreter at Superior Court of California, County of Los Angeles, Court-Certified Interpreter at Freelance Interpreter (Spanish/English), Certified Associate at Lee Hecht Harrison
Location:
Greater Los Angeles Area
Industry:
Professional Training & Coaching
Work:
Superior Court of California, County of Los Angeles - Los Angeles County since Feb 2012
Court Interpreter

Freelance Interpreter (Spanish/English) - Greater Los Angeles Area since Nov 2011
Court-Certified Interpreter

Lee Hecht Harrison - Pasadena, CA since Oct 2010
Certified Associate

DBM Oct 1996 - Jun 2009
Sales Associate
Education:
UCLA 1984 - 1989
Bachelor of Arts (B.A.), Political Science
UCLA Extension 2010 - 2011
Certificate, Translation and Interpretation (Spanish/English)
Languages:
Spanish
French
Certifications:
Certified Court Interpreter - Spanish/English, Judicial Council of CA
Robert Guerrero Photo 2

Mdc Operations Systems Analyst At Toyota Motor Sales

View page
Position:
MDC Operations Systems Analyst/Vendor Manager at Toyota Motor Sales
Location:
Greater Los Angeles Area
Industry:
Information Technology and Services
Work:
Toyota Motor Sales - 450 w. Apra st. Rancho Dominquez since Oct 2012
MDC Operations Systems Analyst/Vendor Manager

Toyota Motor Sales Jun 2008 - Oct 2012
Security Systems Analyst/Vendor Manager

Toyota Motor Sales USA Apr 1995 - Jun 2008
IT System Analyst

Toyota - Torrance Ca. Mar 1983 - Jun 1990
Toyota PDC Warehouseman
Education:
UCI 1997 - 2001
Associate of Science (A.S.), MIS
UCI
Robert Guerrero Photo 3

Staff Engineer At Earthlink

View page
Position:
Staff Engineer at Earthlink
Location:
Greater Los Angeles Area
Industry:
Information Technology and Services
Work:
Earthlink since Sep 2007
Staff Engineer

Countrywide 2007 - 2008
Sr. Server Engineer

Countrywide Bank 2007 - 2008
Sr. Server Engineer

EarthLink 2000 - 2007
Sr. Systems Administrator

Southern California Physicians Insurance Exchange Feb 1999 - Feb 2000
Network Analyst
Robert Guerrero Photo 4

Project Manager At Taco Bell

View page
Position:
Project manager at Taco Bell
Location:
Greater Los Angeles Area
Industry:
Restaurants
Work:
Taco Bell
Project manager
Robert Guerrero Photo 5

Ceo At Proteonova

View page
Position:
CEO at ProteoNova
Location:
Greater Los Angeles Area
Industry:
Biotechnology
Work:
ProteoNova
CEO
Robert Guerrero Photo 6

Account Manager At Dbm

View page
Position:
Account Manager at DBM
Location:
Greater Los Angeles Area
Industry:
Management Consulting
Work:
DBM
Account Manager
Robert Guerrero Photo 7

Supervisor At Unilever

View page
Position:
supervisor at Unilever
Location:
Greater Los Angeles Area
Industry:
Consumer Goods
Work:
Unilever
supervisor
Robert Guerrero Photo 8

Robert Guerrero Monterey, CA

View page
Work:
home depot
Alhambra, CA
Feb 2006 to Oct 2013
Supervisor

crothall inc
Los Angeles, CA
Feb 2005 to Apr 2006
Custodian

pep boys
San Gabriel, CA
Jan 2005 to Mar 2006
Mechanic

California. auto dealers EXCHANGE
Rosemead, CA
May 2004 to Feb 2005
Supervisor

Education:
RIO HONDO
Whittier, CA
1999 to 2000
criminal. justice

mark kepppell hs
Alhambra, CA
1998 to 1999
high school diploma in General

Skills:
forklift operator, great customer service, computers, bilingual

Business Records

Name / Title
Company / Classification
Phones & Addresses
Robert R. Guerrero
President
PROTEONOVA, INC
Business Services at Non-Commercial Site
814 S Euclid Ave, Pasadena, CA 91106
Robert Guerrero
President
Nations of The World Community Inc
1101 W Vly Blvd, Alhambra, CA 91803
Robert S. Guerrero
President
ST. CYR SPORTSWEAR MANUFACTURING, INC
3326 S Main St #3RD, Los Angeles, CA 90007
Robert Guerrero
Principal
Gmv International Holdings, LLC
Holding Company
7668 El Camino Real, Carlsbad, CA 92009
7668 El Camino, Carlsbad, CA 92009
Robert Guerrero
Pastor
Woodland Park
Religious Organization · Religious Organizations
2255 Felicita Rd, Escondido, CA 92029
(760) 745-9083

Publications

Wikipedia References

Robert Guerrero Photo 9

Robert Guerrero

Wikipedia

Robert Guerrero

View page

Robert Joseph Guerrero (born March 27, 1983 in Gilroy, California) is a professional American boxer of Mexican descent. Nicknamed The Ghost, he is the ...

Us Patents

Method For Making Targeted Therapeutic Agents Directed To Soluble Targets

View page
US Patent:
20120237539, Sep 20, 2012
Filed:
Apr 25, 2012
Appl. No.:
13/455598
Inventors:
Richard B. WILLIAMS - South Pasadena CA, US
Robert GUERRERO - Pasadena CA, US
Assignee:
Proteonova, Inc. - Pasadena CA
International Classification:
C12P 21/00
A61P 37/04
A61K 39/00
US Classification:
4241921, 435 681
Abstract:
Provided herein are methods for making targeted therapeutics that target soluble agents such as toxins, venoms, and factors that alter physiological biopathways as well as methods of using such therapeutics to treat patients or patient populations to reduce, eliminate, or inactivate, detrimental soluble agents that such patients or patient populations have been exposed to. In several embodiments the targeted therapeutics comprise a portion that interacts with a soluble agent of interest and a second portion that interacts with a subject's immune system, which enables treatment of a patient for exposure to the soluble agent.

Method For Making Targeted Therapeutic Agents Directed To Soluble Targets

View page
US Patent:
20130129769, May 23, 2013
Filed:
Jan 10, 2013
Appl. No.:
13/738861
Inventors:
Robert Guerrero - Pasadena CA, US
Assignee:
PROTEONOVA, INC. - Pasadena CA
International Classification:
A61K 39/00
C12N 15/10
US Classification:
4241921, 506 9
Abstract:
Provided herein are methods for making targeted therapeutics that target soluble agents such as toxins, venoms, and factors that alter physiological biopathways as well as methods of using such therapeutics to treat patients or patient populations to reduce, eliminate, or inactivate, detrimental soluble agents that such patients or patient populations have been exposed to. In several embodiments the targeted therapeutics comprise a portion that interacts with a soluble agent of interest and a second portion that interacts with a subject's immune system, which enables treatment of a patient for exposure to the soluble agent.

Modular Targeted Therapeutic Agents And Methods Of Making Same

View page
US Patent:
20130183312, Jul 18, 2013
Filed:
Mar 8, 2013
Appl. No.:
13/791615
Inventors:
Robert Guerrero - Pasadena CA, US
Assignee:
PROTEONOVA, INC. - Pasadena CA
International Classification:
A61K 39/395
US Classification:
4241361, 435 681, 506 9
Abstract:
Provided herein are methods for making targeted therapeutics. In several embodiments, the therapeutics are directed against soluble agents such as toxins, venoms, and/or other factors that alter physiological biopathways as well as methods of using such therapeutics to treat patients or patient populations to reduce, eliminate, or inactivate, detrimental soluble agents that such patients or patient populations have been exposed to. In several embodiments, the therapeutics are directed to patient-specific disease markers. In several embodiments, the methods comprise screening a library comprising proteins linked to their cognate mRNAs to identify mRNA-protein pairs that bind to the diseased cells, isolating one or more proteins from the identified mRNA-protein pairs, and conjugating the isolated protein(s) to a therapeutic agent.

Method Of Detecting The Tumors Using Ring Shaped Particles As A Tumor Marker

View page
US Patent:
54590353, Oct 17, 1995
Filed:
Dec 9, 1992
Appl. No.:
7/987678
Inventors:
Robert R. Guerrero - Pasadena CA
Donald E. Rounds - Altadena CA
Assignee:
AMDL, Inc. - Pasadena CA
International Classification:
C12Q 168
C12Q 100
C07K 1500
C07H 1700
US Classification:
435 6
Abstract:
A method is described for identifying and localizing tumors in a patient. The method comprises assaying extracellular fluids, isolated from a patient, for the presence of elevated levels of ring shaped particles (RSP). The assay employs binding labeled RSP specific binding agent to the RSP.

Method For Detecting The Presence Of Ring Shaped Particle Tumor Marker

View page
US Patent:
56356056, Jun 3, 1997
Filed:
Mar 6, 1995
Appl. No.:
8/398922
Inventors:
Robert R. Guerrero - Pasadena CA
Donald E. Rounds - Altadena CA
Assignee:
AMDL, Inc. - Tustin CA
International Classification:
C07K 114
C07K 116
C07K 122
C07K 130
US Classification:
530412
Abstract:
A method is described for identifying, localizing and treating tumors in a patient. The method comprises assaying extracellular fluids, isolated from a patient, for the presence of elevated levels of ring shaped particles (RSP). The assay employs binding labeled RSP specific binding agent to the RSP.

Modular Targeted Therapeutic Agents And Methods Of Making Same

View page
US Patent:
20190231870, Aug 1, 2019
Filed:
Dec 21, 2018
Appl. No.:
16/231099
Inventors:
- Pasadena CA, US
Robert Guerrero - Pasadena CA, US
International Classification:
A61K 39/395
C12N 15/10
G01N 33/68
C12N 15/62
C07K 16/30
G01N 33/531
Abstract:
Provided herein are methods for making targeted therapeutics. In several embodiments, the therapeutics are directed against soluble agents such as toxins, venoms, and/or other factors that alter physiological biopathways as well as methods of using such therapeutics to treat patients or patient populations to reduce, eliminate, or inactivate, detrimental soluble agents that such patients or patient populations have been exposed to. In several embodiments, the therapeutics are directed to patient-specific disease markers. In several embodiments, the methods comprise screening a library comprising proteins linked to their cognate mRNAs to identify mRNA-protein pairs that bind to the diseased cells, isolating one or more proteins from the identified mRNA-protein pairs, and conjugating the isolated protein(s) to a therapeutic agent.
Robert J Guerrero from Oceanside, CADeceased Get Report